کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1362197 | 981480 | 2011 | 5 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Furoxan nitric oxide donor coupled chrysin derivatives: Synthesis and vasculoprotection Furoxan nitric oxide donor coupled chrysin derivatives: Synthesis and vasculoprotection](/preview/png/1362197.png)
A series of furoxan-based nitric oxide-releasing chrysin derivatives were synthesized. Pharmacological assays indicated that all chrysin derivatives exhibited in vitro inhibitory activities against aldose reductase and advanced glycation end-product formation. Some chrysin derivatives were also found to increase the glucose consumption of HepG2 cells. Furthermore, the compounds released a low amount of NO in the presence of l-cysteine (range from 0.20% to 1.89%). These hybrid furoxan-based NO donor chrysin derivatives offer a mutual prodrug design concept for the development of therapeutic or preventive agents for vascular complications due to diabetes.
A group of hybrid furoxan based nitric oxide-releasing chrysin derivatives was synthesized. All these chrysin derivatives released NO upon incubation with PBS at pH 7.4, exhibited inhibitory activities against aldose reductase and advanced glycation end-products formation in vitro. And some of them were even found to increase the glucose consumption of HepG2 cells.Figure optionsDownload as PowerPoint slide
Journal: Bioorganic & Medicinal Chemistry Letters - Volume 21, Issue 4, 15 February 2011, Pages 1222–1226